global LDL test market accounted for over USD 6,500 million in 2017 and is expected to grow at a CAGR of 6.5% during the forecast period, 2019–2026

LDL Test Market

Low-density lipoprotein, considered as bad cholesterol, builds-up in arteries, effectively clogging them and ultimately, leading to a stroke or a heart attack. The LDL test determines the risk of heart related diseases and disorders. 

Heart diseases such as high-pressure, angina, stroke, carotid artery disease, and peripheral arterial disease have become prevalent due to high cholesterol levels. According to the Centers for Disease Control and Prevention (CDC), approximately 1 of every 13 Americans aged above 18 years has been diagnosed with coronary artery disease (CAD). High cholesterol level leads to hypertension and is thus, a menace worldwide. Diabetes reduces the good cholesterols and raises bad cholesterols and triglycerides, that increases the risk for stroke and heart diseases. Thus, high prevalence of diabetes globally is also  one of the market drivers. For instance, according to the World Health Organization (WHO), approximately 422 million people suffer from diabetes around the globe.

The Major Players Covered in this Report:
Hoffmann-La Roche Ltd, Sekisui Diagnostics, Express Biotech International, Sigma-Aldrich Co. LLC, Randox Laboratories Ltd, Reckon Diagnostics, Quest Diagnostics Incorporated, DiaSys Diagnostics India Private Limited, Eurofins Scientific, Kopibeskyttet Unilabs Labhåndbok, Atlas Medical,Eurolyser Diagnostica GmbH, Laboratory Corporation of America, Diazyme Laboratories, Inc., and Thermo Fisher Scientific Inc.

The global LDL test market accounted for over USD 6,500 million in 2017 and is expected to grow at a CAGR of 6.5% during the forecast period, 2019–2026.

Get a Sample PDF Report:
https://straitsresearch.com/report/LDL-Test-market/request-sample

By Type, LDL-C, LDL-P, LDL-B, Others,

By Component, Devices, Syringes & Needles, Spectrophotometers, Kits & Reagents, Toxicity Assays Kit, Blood Chemistry Assays Kit, Cytotoxicity Assays Kit, Others,

By Application, Atherosclerosis, Obesity, Dyslipidemia, Diabetes, Angina, Stroke Carotid Artery Disease, Peripheral Arterial Disease, Others, ,

By End User, Hospitals, Clinics, Pharmaceutical and Biotechnological Companies, Others

Market Segmentation

The global LDL test market can be segmented by type, component, application, and end user.

Based on type, the market can be segmented into LDL-C, LDL-P, LDL-B, and others. The LDL-C segment is expected to hold a major market share during the forecast period, owing to the increasing incidences of high cholesterol levels among the population.

Based on component, the market can be segmented into devices, kits & reagents and others. The kits & reagents segment is expected to hold a major market share during the forecast period. The kits & reagents segment has been further sub-segmented into toxicity assays kit, blood chemistry assays kit, and cytotoxicity assays kit. The devices segment has been further sub-segmented into syringes & needles, spectrophotometers and others.

Regional Analysis For LDL Test Market:

North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

In this study, the years considered to estimate the market size of the LDL Test are as follows:

History Year: 2014-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2021 to 2026

Why buy this report right now?

Historical inferences, findings & analysis of the market for the duration 2016 to 2018
Projections and performance forecast analysis for the duration 2019 to 2026
Production and consumption point-of-view (POV) analysis
Market driver, restraint and opportunity analysis to define market dynamics, covering industry, regulatory, innovation, technological & pricing trends
Comprehensive competitive landscape mapping with recent developments, covering market leadership, competency, sustainability, and prospects

For More Details On this Report:
https://straitsresearch.com/report/LDL-Test-market

Contact Us:

Company Name: Straits Research
Email: sales@straitsresearch.com
Phone:
+1 646 480 7505 (U.S.)
+91 8087085354 (India)
+44 208 068 9665 (U.K.)

About Us:

Regardless of whether you're looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with what customers purchase. We overcome the issues of our customers by recognizing and deciphering just the target group, while simultaneously generating leads with the highest precision. We seek to collaborate with our customers to deliver a broad spectrum of results through a blend of market and business research approaches. This approach of using various research and analysis strategies enable us to determine greater insights by eliminating the research costs. Moreover, we're continually developing, not only with regards to where we measure, or who we measure but in how our visions can enable you to drive cost-effective growth.

This release was published on openPR.